Clinical Trial Update: Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Dexmedetomidine and Propofol in patients with systemic inflammatory response syndrome (SIRS) focusing on delirium and neuroinflammatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• PROPOFOL (Propofol)

Snippet

Sponsor: Moscow Regional Research and Clinical Institute (MONIKI) | Conditions: Delirium | Phase 4 | Status: WITHDRAWN